首页> 外文期刊>Advances in therapy. >The H-Wave small muscle fiber stimulator, a nonpharmacologic alternative for the treatment of chronic soft-tissue injury and neuropathic pain: an extended population observational study.
【24h】

The H-Wave small muscle fiber stimulator, a nonpharmacologic alternative for the treatment of chronic soft-tissue injury and neuropathic pain: an extended population observational study.

机译:H-Wave小肌纤维刺激物,一种用于治疗慢性软组织损伤和神经性疼痛的非药物替代品:一项广泛的人群观察性研究。

获取原文
获取原文并翻译 | 示例
       

摘要

In a previous study, the H-Wave small-muscle fiber stimulator significantly reduced chronic pain and restored physical function among patients with pain in the lower and upper extremities and spine. In this extended population observational study, a cross-sectional,computer-administered 10-item survey was administered to 6774 patients (3367 men [49.7%], 3406 women [50.3%], and 1 sex not reported [<1%]; mean+/-SD age, 45.28+/-10.08 y; range, 18-65 y) with chronic soft-tissue injury or neuropathic pain to assess their therapeutic response. The mean+/-SE duration of self-administered H-Wave treatment before the survey was completed was 87.35+/-1.39 d. Sixty-five percent of study participants reported a reduced or eliminated need for pain medication; 79% reported improved functional capacity or activity; and 78% reported 25% or greater reduction of pain. This cross-sectional evaluation represents the largest outcome study on the benefits of the H-Wave device in patients with chronic soft-tissue injury or neuropathic pain. The results suggest that this nonpharmacologic approach may provide an important alternative to standard pharmacologic treatment.
机译:在先前的研究中,H-Wave小肌纤维刺激器显着减轻了上下肢和脊柱疼痛患者的慢性疼痛并恢复了身体机能。在这项扩展的人群观察研究中,对6774例患者进行了横断面计算机管理的10个项目的调查(3367例男性[49.7%],3406例女性[50.3%]和1个未报告的性别[<1%];平均+/- SD年龄为45.28 +/- 10.08y;范围为18-65y),患有慢性软组织损伤或神经性疼痛,以评估其治疗反应。在调查完成之前,自我管理的H-Wave治疗的平均+/- SE持续时间为87.35 +/- 1.39 d。 65%的研究参与者表示减少或消除了对止痛药的需求; 79%的人报告说其功能能力或活动有所改善; 78%的人表示疼痛减轻了25%以上。这项横断面评估代表了H-Wave装置对慢性软组织损伤或神经性疼痛患者的益处的最大结果研究。结果表明,这种非药物方法可能为标准药物治疗提供重要的替代方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号